Article Details
Retrieved on: 2019-12-07 13:03:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Seres Therapeutics (NASDAQ:MCRB)'s stock had its “buy” rating reiterated by HC Wainwright in a report released on Thursday, November 21st, Stock ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here